16 completed, 3 recruiting, 2 withdrawn, 1 terminated. 23 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 23 | Completed 16, Recruiting 3, Withdrawn 2, Terminated 1, Unknown 1 |
| Phase 2 | 6 | Recruiting 3, Withdrawn 2, Completed 1 |
Follow Cilostazol: new trials by email Literature Review of Cilostazol trials Research Report on Cilostazol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease Standard therapy, Cilostazol - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-01 | 2025-11-25 |
| BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers Cilostazol Tablet 100 mg, PMR Tablet 145 mg - Intermittent Claudication | Phase 1 | Completed | Genovate Biotechnology Co., Ltd., | 40 | 2023-11-28 | 2024-02-23 |
| BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers Cilostazol Tablet 100 mg, PMR Tablet 135 mg - Intermittent Claudication | Phase 1 | Completed | Genovate Biotechnology Co., Ltd., | 25 | 2022-07-05 | 2023-04-13 |
| Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers Cilostazol 100 mg, PMR 135 mg - Intermittent Claudication | Phase 1 | Terminated | Genovate Biotechnology Co., Ltd., | 19 | 2022-04-23 | 2025-03-13 |
| Efficacy of Cilostazol in Prevention of Peripheral Neuropathy Cilostazol, Placebo - Peripheral Neuropathy, Breast Cancer | Phase 1 / Phase 2 | Completed | Mansoura University | 71 | 2022-03-28 | 2023-03-15 |
| The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis Cilostazol 50 MG, Placebo - Osteoarthritis | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2021-03-01 | 2025-07-14 | |
| Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease Cilostazol 50 MG, Placebo - Fatty Liver, Nonalcoholic | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2021-02-16 | 2025-07-14 | |
| Retina is a Marker for Cerebrovascular Heath Cilostazol - Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 100 | 2021-02-09 | 2026-08-03 |
| Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers Cilostazol 100 mg, PMR 200 mg - Intermittent Claudication | Phase 1 | Completed | Genovate Biotechnology Co., Ltd., | 28 | 2019-02-11 | 2019-05-14 |
| Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers Cilostazol 100 mg, PMR 150 mg, PMR 200 mg - Intermittent Claudication | Phase 1 | Completed | Genovate Biotechnology Co., Ltd., | 21 | 2018-03-06 | 2018-07-10 |
| Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) Cilostazol, Leucovorin, Pirfenidone - Multiple Sclerosis | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 250 | 2017-08-11 | 2026-10-20 |
| Pharmacodynamic Study of Cilostazol in Healthy Volunteers Cilostazol, Acetylsalicylic acid, Clopidogrel - Healthy | Phase 1 | Completed | Otsuka Pharmaceutical Co., Ltd. | 77 | 2015-08-01 | 2021-10-13 |
| Cilostazol-Simvastatin Drug Interaction Study Simvastatin, Pravastatin, Cilostazol - Dyslipidemias, Peripheral Artery Disease | Phase 1 | Unknown | Ajou University School of Medicine | 20 | 2015-04-01 | 2015-05-01 |
| Pharmacodynamic Drug Interaction Between Cilostazol and Statins Cilostazol, Simvastatin, Rosuvastatin - Healthy | Phase 1 | Completed | Samsung Medical Center | 63 | 2012-06-01 | 2015-05-27 |
| Effect of Cilostazol on the Pharmacokinetics of Simvastatin simvastatin/cilostazol - Healthy | Phase 1 | Completed | Samsung Medical Center | 20 | 2011-06-01 | 2015-05-20 |
| A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions Cilostazol - Intermittent Claudication | Phase 1 | Completed | Otsuka Frankfurt Research Institute GmbH | 44 | 2008-12-01 | 2011-09-09 |
| Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo Cilostazol, Ginkgo biloba and placebo - Healthy | Phase 1 | Completed | SK Chemicals Co., Ltd. | 40 | 2007-05-01 | 2009-01-13 |
| Fasted Bioavailability Study of Cilostazol Tablets, 50mg Cilostazol 50 mg Tablets, Cilostazol (Pletal®) 50 mg Tablets - Therapeutic Equivalency, Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 32 | 2004-06-01 | 2009-12-22 |
| Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg Cilostazol Tablets 100 mg, Pletal® Tablets 100 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 44 | 2004-03-01 | 2024-04-23 |
| Fasted Bioavailability Study of Cilostazol Tablets, 100 mg Cilostazol 100 mg Tablets, Cilostazol (Pletal®) 100 mg Tablets - Therapeutic Equivalency | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 32 | 2004-03-01 | 2009-12-22 |
Showing 20 of 23. Sign in to see all of them.
Intermittent Claudication (6) · Peripheral Arterial Disease (6) · Breast Neoplasms (1) · CADASIL (1) · Cerebral Small Vessel Diseases (1) · Dyslipidemias (1) · Fatty Liver (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Non-alcoholic Fatty Liver Disease (1) · Osteoarthritis (1) · Pain (1) · Peripheral Nervous System Diseases (1)
Genovate Biotechnology Co., Ltd., (5) · Mutual Pharmaceutical Company, Inc. (2) · Sadat City University (2) · Samsung Medical Center (2) · Teva Pharmaceuticals USA (2) · Ajou University School of Medicine (1) · Mansoura University (1) · Mayo Clinic (1) · Mylan Pharmaceuticals Inc (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Otsuka Frankfurt Research Institute GmbH (1) · Otsuka Pharmaceutical Co., Ltd. (1) · SK Chemicals Co., Ltd. (1) · Sandoz (1) · Tanta University (1)
United States (10) · Egypt (4) · South Korea (4) · Germany (2)
Dilip K Guha-Ray, M.D. (2) · Bibiana Bielekova, M.D. (1) · Doo-Yeoun Cho, MD (1) · Gaetano Morelli, M.D. (1) · Jae Gook Shin, MD,PhD (1) · Jae-Wook Ko, MD, PhD (1) · JaeWook Ko, MD (1) · James D. Carlson, Pharm.D. (1) · Kayce Morton (1) · Margarete Mueller, Dr. (1) · Michelle P Lin, MD, MPH (1) · Osamu Sato (1) · Steven Herrmann, M.D., Ph. D. (1) · Tamatha F. Zemzars (1) · Walter A Parham, M.D. (1)